Clinical Trial Update: EnSite Precision 2.1 Feasibility Study

View source ↗

Summary

A feasibility study evaluating Abbott's EnSite Precision 2.1 for arrhythmia management has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmias

Drugs mentioned

• EnSite Precision 2.1

Snippet

Sponsor: Abbott Medical Devices | Conditions: Arrhythmias | Status: COMPLETED